A European initiative for your health

EIT Health is one of the largest healthcare initiatives worldwide. Its goal is to sustainably advance the foundations of healthcare and thus promote the future conditions for healthier living and wellbeing of people across Europe. EIT Health is leveraging the expertise of more than 130 leading organisations spanning key areas of healthcare such as Pharma, MedTech, Payers, Research Institutions and Universities. Chosen by the European Institute of Innovation and Technology (EIT) to form EIT Health, the consortium offers best-in-class research capabilities, higher education and business expertise. With a budget of 2 billion EUR over the next decade, it will purposefully invest in Europe’s best entrepreneurial talents and creative minds to foster the development and commercialisation of smart product and service solutions in the health sector, addressing the challenges imposed by demographic change and ageing societies.

Europe map_new_2016_04_mayor

A truly European network for personal opportunities and regional growth

The regional structure of EIT Health extends across Europe. With its headquarters in Munich (Germany), EIT Health has established six co-location centres in London (UK/Ireland), Stockholm (Scandinavia), Barcelona (Spain), Paris (France), Mannheim and Heidelberg (Germany/Switzerland) and Rotterdam (Belgium/Netherlands), which are expected to become operational by October 2015. All six co-location centres are defined by the EU Innovation Scorecard as high innovation performers and all locations provide a shared physical space, with access to laboratories, test beds, offices and seminar rooms that will promote close cooperation.

With the twin goals of leveraging diversity and driving the potential of emerging innovation clusters, EIT Health has added the “EIT Health InnoStars” to its network. These regional clusters consist of industry partners, academia, and health providers linked to seven regions in six countries – Croatia, Hungary, Poland, Portugal, Italy, and Wales. Each region represents research specialties and socio-economic structures that ideally complement the EIT Health co-locations centres while ensuring wider participation and outreach across Europe’s multifaceted innovation landscape.

Our management

Sylvie Bove


Jan-Philipp Beck


Felix Hage

Director of Finance

Ursula Mühle

Director of Education

Andy Browning

Director of Innovation

Kurt Höller

Director of Business Creation

Sabine Schumann

Head of Communications




Our supervisory board

Koen Debackere

Chairman of the Supervisory Board


Isabelle Thizon De Gaulle
Head of Scientific relations and Initiatives, Sanofi

Patrick Levy

President of Joseph Fourier University

Ursula Redeker

Managing Director and Spokesperson Executive Board, Roche Diagnostics GmbH
Wolfgang A. Herrmann

Wolfgang A. Herrmann

President of the Technische Universität München

Per Matsson

Thermo Fisher Scientific, ImmunoDiagnostic Division

Alexander von Gabain

Deputy Vice-Chancellor for Innovation and Commercial Outreach at the Karolinska Institute
Lydia Montandon

Lydia Montandon

Atos Research & Innovation Business Development director

Josep Samitier

Rector Representative at the University of Barcelona and Director of the Institute for Bioengineering of Catalonia

Elio Riboli

Director School of Public Health, Imperial College

Robert McCarthy

Program Director – Innovation, Business Development and Operations – Ireland Lab
Branch Manager – IBM PDL

Hans Hofstraat

Vice President Healthcare Strategic Partnerships, Philips Research

Miklós Szócska

Minister of State for Health of the Hungarian Government 2010-2014

Joaquim Neto Murta, MD, PhD

Head Department Ophthalmology, University Hospital Coimbra

Core partners



Air Liquide Santé International
LOGO Uni Grenoble Alpes


UCB Biosciences GmbH

UK / Ireland

Belgium – Netherlands




Associate partners